Jennifer Crombie, MD, discusses classification of diffuse large B-cell lymphoma (DLBCL) into distinct subtypes and treatment decisions based on molecular classifications.
Jennifer Crombie, MD
Advertisement
Articles by Jennifer Crombie, MD
Advertisement
Latest Updated Articles
- Classifying DLBCL Subtypes for Optimal Treatment
October 28th 2019
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Relacorilant Combo in Platinum-Resistant Ovarian Cancers
2
FDA Clears Investigator-Initiated IND for SRN-101 in Recurrent High-Grade Glioma
3
Navigating New Horizons in Neuroendocrine Prostate Cancer
4
The Intersection of Technology and Psycho-Oncology Care
5